Digital karyotyping: An update of its applications in cancer

Molecular Diagnosis and Therapy

Volumn 10, Issue 4, 2006, Pages 231-237

  Salani, Ritu ^a   Chang, Chao Ling ^a   Cope, Leslie ^a   Wang, Tian Li ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOMATION; CANCER GENETICS; COMPARATIVE GENOMIC HYBRIDIZATION; DATA BASE; DIGITAL COMPUTER; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENE TECHNOLOGY; GENOME ANALYSIS; HUMAN; KARYOTYPING; ONCOGENE; ONLINE SYSTEM; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 33747141409     PISSN: 11771062     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03256461     Document Type: Review

References (18)

1. Wang TL, Maierhofer C, Speicher MR, et al. Digital karyotyping. Proc Natl Acad Sci U S A 2002; 99 (25): 16156-61
2. Velculescu VE, Zhang L, Vogelstein B, et al. Serial analysis of gene expression. Science 1995 Oct 20; 270 (5235): 484-7
3. Parrett TJ, Yan H. Digital karyotyping technology: exploring the cancer genome. Expert Rev Mol Diagn 2005 Nov; 5 (6): 917-25
4. Feuk L, Carson AR, Scherer SW. Structural variation in the human genome. Nat Rev Genet 2006 Feb; 7 (2): 85-97
5. Margulies M, Egholm M, Altman WE, et al. Genome sequencing in microfabricated high-density picolitre reactors. Nature 2005 Sep 15; 437 (7057): 376-80
6. Shendure J, Porreca GJ, Reppas NB, et al. Accurate multiplex polony sequencing of an evolved bacterial genome. Science 2005 Sep 9; 309 (5741): 1728-32
7. The Cancer Genome Anatomy Project. Digital karyotyping data viewer [online]. Available from URL: http://cgap-stage.nci.nih.gov/SAGE/DKViewHome [Accessed 2006 Jun 9]
8. Hu M, Yao J, Cai L, et al. Distinct epigenetic changes in the stromal cells of breast cancers. Nat Genet 2005 Aug; 37 (8): 899-905
9. Hahn SA, Hoque AT, Moskaluk CA, et al. Homozygous deletion map at 18q21.1 in pancreatic cancer. Cancer Res 1996 Feb 1; 56 (3): 490-4
10. Schutte M, da Costa LT, Hahn SA, et al. Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region. Proc Natl Acad Sci U S A 1995 Jun 20; 92 (13): 5950-4
11. Kamb A, Gruis NA, Weaver-Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994 Apr 15; 264 (5157): 436-40
12. Teng DH, Perry WL, Hogan JK, et al. Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor. Cancer Res 1997 Oct 1; 57 (19): 4177-82
13. Su GH, Hilgers W, Shekher MC, et al. Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene. Cancer Res 1998 Jun 1; 58 (11): 2339-42
14. Nakayama K, Nakayama N, Davidson B, et al. Homozygous deletion of MKK4 in ovarian serous carcinoma. Cancer Biol Ther 2006 Jun 9, 5 (6) Epub ahead of print
15. Boon K, Eberhart CG, Riggins GJ. Genomic amplification of orthodenticle homologue 2 in medulloblastomas. Cancer Res 2005 Feb 1; 65 (3): 703-7
16. Di C, Liao S, Adamson DC, et al. Identification of OTX2 as a medulloblastoma oncogene whose product can be targeted by all-trans retinoic acid. Cancer Res 2005 Feb 1; 65 (3): 919-24
17. Shih IeM, Sheu JJ, Santillan A, et al. Amplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinoma. Proc Natl Acad Sci U S A 2005 Sep 27; 102 (39): 14004-9
18. Wang TL, Diaz LA, Romans K, et al. Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients. Proc Natl Acad Sci U S A 2004 Mar 2; 101 (9): 3089-94